M. Sc, CEO.
Andreas Gerward
Andreas has during the last 10 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se +46 (0)730 808 397Below is an overview of the Company’s largest owners as of 30 September 2025
| Name | Total shares | Percentage |
|---|---|---|
| Chalmers Ventures AB | 7 559 274 | 11.8% |
| Avanza Pension | 5 620 302 | 8.7% |
| Bent Balldin | 2 100 000 | 3.3% |
| ALMI Invest Västsverige ABLiv | 1 935 584 | 3.0% |
| Handelsbanken | 1 439 494 | 2.2% |
| Fredrik Pettersson | 1 300 000 | 2.0% |
| Björn Sjöberg | 1 240 000 | 1.9% |
| Ålandsbanken | 1 236 283 | 1.9% |
| Peter Olund | 1 163 800 | 1.8% |
| Joel Hagman | 1 146 568 | 1.8% |
